IDH1 MutationPhase 2NCT06707493
Ivosidenib as Post-HSCT Maintenance for AML
Ivosidenib, Placebo
182 Phase 2 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma182 studies
IDH1 MutationPhase 2NCT06707493
Ivosidenib, Placebo
Acute Myeloid LeukemiaPhase 2NCT03586609Papers
Azacitidine, Cladribine, Cytarabine, Venetoclax
Large B-cell LymphomaPhase 2NCT06500273
cemacabtagene ansegedleucel, Fludarabine, Cyclophosphamide, Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Richter SyndromePhase 2NCT06863402
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Echocardiography
Mantle Cell LymphomaPhase 2NCT06252675
Obinutuzumab, Glofitamab, Pirtobrutinib, Tumor Imaging
T-Cell Large Granular Lymphocyte LeukemiaPhase 2NCT05592015
Ruxolitinib
Waldenstrom MacroglobulinemiaPhase 2NCT07231952
Pirtobrutinib, Venetoclax, Rituximab
Autologous Stem Cell TransplantPhase 2NCT06377540
Pembrolizumab, Autologous stem cell transplant, Carmustine, Etoposide
T-cell Acute Lymphoblastic LeukemiaPhase 2NCT06514794
WU-CART-007
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPhase 2NCT07685717
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography
Follicular LymphomaPhase 2NCT06350318
Zanubrutinib, Rituximab
Peripheral T Cell LymphomaPhase 2NCT06630091
Golidocitinib, Cyclophosphamide, Doxorubicin, Vincristine
Hematological MalignanciesPhase 2NCT04634552Papers
Talquetamab
Multiple MyelomaPhase 2NCT07149857
Cilta-cel, Cyclophosphamide, Induction therapy, Fludarabine
Follicular LymphomaPhase 2NCT06563596
Zanubrutinib, Rituximab, Epcoritamab
Recurrent Acute Myeloid LeukemiaPhase 2NCT03629171Papers
Liposome-encapsulated Daunorubicin-Cytarabine, Venetoclax
Large B-cell LymphomaPhase 2NCT06045247
Prednisone, Rituximab, Cyclophosphamide, Vincristine
B-Cell Lymphoblastic LeukemiaPhase 2NCT06144606
Tecartus
B Cell LymphomaPhase 2NCT06213311
Glofitamab, Obinutuzumab, Axi-cel
Multiple MyelomaPhase 2NCT05789303
Belantamab mafodotin, Carfilzomib, Pomalidomide, Dexamethasone
Relapsed Classic Hodgkin LymphomaPhase 2NCT04561206
Brentuximab Vedotin, Nivolumab
Recurrent Grade 1 Follicular LymphomaPhase 2NCT06453044
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Mosunetuzumab
Lymphoma, Non-HodgkinPhase 2NCT02693535Papers
Sunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT), Olaparib (CLOSED TO ENROLLMENT)
Multiple MyelomaPhase 2NCT04661137Papers
Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG, Carfilzomib